PCN524 EUROPEAN REAL-WORLD TREATMENT PATTERNS OF SYSTEMIC THERAPIES FOR SECOND LINE (2L) HEPATOCELLULAR CARCINOMA (HCC) PATIENTS WHO PREVIOUSLY RECEIVED SORAFENIB
| Autor: | Kiiskinen, U., Rider, A., Leith, A., Khela, K., Girvan, A., Nitu, I., Senin, T., Jen, M.H. |
|---|---|
| Zdroj: | In Value in Health November 2019 22 Supplement 3:S539-S540 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect